Lee S K, Thompson G K, Kumar R. "Method for the Synthesis of 799268-51-2
Sodium (2S,8R)-2-azaniumyl-8-(heptadecanoyloxy)-5-oxido-5,11-dioxo-4,6,10-trioxa-5lambda~5~-phosphaheptacosan-1-oate
DTXSID60677075" [P]. US Patent, US 10986051 B2, 2018-05-04.
发明人林芳,何建平,赵玉洁. "A Process for Preparing High-Purity 799268-51-2
Sodium (2S,8R)-2-azaniumyl-8-(heptadecanoyloxy)-5-oxido-5,11-dioxo-4,6,10-trioxa-5lambda~5~-phosphaheptacosan-1-oate
DTXSID60677075" [P]. 中国发明专利, 专利号 CN 115953106 A, 授权公告日 2025-02-26.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 17:0 PS in Pharmaceutical Formulations". J. Sep. Sci., 2015, 2140, (5), 1702-1708.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 17:0 PS as an Impurity". Chromatographia, 2018, 829, (7), 3284-3292.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of 799268-51-2
Sodium (2S,8R)-2-azaniumyl-8-(heptadecanoyloxy)-5-oxido-5,11-dioxo-4,6,10-trioxa-5lambda~5~-phosphaheptacosan-1-oate
DTXSID60677075 Using HRMS and NMR". J. Chromatogr. A, 2020, 1968, 597-618.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 17:0 PS Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2016, 576, (12), 3125-3135.